Sepsis as a leading cause of death in intensive care medicine is characterised by a systemic inflammatory response to bacterial products during infection. 1 Infections with both Gram-positive and Gram-negative bacteria account for sepsis and are clinically indistinguishable. 2 Interestingly, males suffer from a higher risk for sepsis compared to females. 3 A study on different inbred strains of mice indicated also a genetic component influencing sepsis development. 4 CD14 is a receptor recognising lipopolysaccharide (LPS -part of the envelope of Gram-negative bacteria), 5 but also a receptor for peptidoglycans and lipoteichoic acid, which are characteristic constituents of Gram-positive bacteria. 6, 7 CD14 is a glycoprotein localised on the cell surface of myeloid cells, with a high expression on monocytes and macrophages 5 and in addition is found in two soluble forms in plasma. 8 Soluble CD14 confines LPS responsiveness also to cells with a lack of CD14 expression. 9 The importance of CD14 in sepsis development was verified in transgenic and CD14 deficient mice. Transgenic mice which express human CD14 develop increased sensitivity to LPS 10 while CD14-deficient mice were found to be highly resistant to shock induced by either live Gram-negative bacteria or LPS. 11 Controversially, the application of soluble CD14 has been shown to protect mice from lethality in LPS-induced shock. 12 The genomic organisation of CD14 13 is well known, and the precise cDNA sequence has recently been verified. 14 As a model for the characterisation of the in vivo relevance of LPS, a common polymorphism in the promoter region of CD14 [15] [16] [17] has recently been described. The TT genotype which was found at 15.6% to 22.0% in different population groups was positively coupled to myocardial infarction. 15, 16 A functional relevance of the polymorphism, which localises close to the regulatory important Sp1 transcription factor binding site, 18 has been shown based on correlation to the membrane expression density of CD14 (mCD14) 15 as well as levels of soluble CD14 (sCD14). 17 A discrepancy in the CD14 polymorphism localisation (alleles are registered in the EMBL database under X74984 and U00699) occurs in previously published papers. [15] [16] [17] Because of several existing transcription starts in the CD14 promoter we have used the translation start as 1 and localised the polymorphism localisation at position −260, 15 while the transcription start site was used by other authors leading to localisation of the polymorphism at position −159. 16, 17 We now have attempted to prove an association between this functionally relevant CD14 promoter genotype and the incidence or outcome of sepsis by examination of 204 severe sepsis patients and 247 controls ( Table 1 ). The distribution of alleles and genotypes of the polymorphism in the CD14 gene was revealed to be in Hardy-Weinberg equilibrium. The allele or genotype frequencies neither differed between patients with severe sepsis and healthy controls nor between males or females. In addition, there was no relation of the polymorphism to mortality of severe sepsis (Table 2) .
Although there is no doubt about the importance of CD14 receptor as a receptor in sepsis development, data about CD14 expression during sepsis are still not completely consistent. Thus a higher level of sCD14 in sepsis patients, compared to controls, has been described repeatedly. [22] [23] [24] Regarding membrane expression both a lower level of mCD14 [25] [26] [27] and no difference in mCD14 expression between normal volunteers and patients with sepsis or septic shock were observed. 28 As described previously, the polymorphism which did not correlate to the incidence or outcome of sepsis in this study, affects both mCD14 density 15 and sCD14 17 levels. TT homozygotes express about 40% more mCD14 compared to carriers of the C allele. Although mouse models indicate a correlation of CD14 overexpression to LPS responsiveness, 29 another in vivo study in mice 11 suggests that such a difference is probably not sufficient to play a role in sepsis development, supporting the results of our study. Contrary to these data, however, recently a disequilibrium of a polymorphism in a plasma protein facilitating LPS dependent activation of CD14 has been detected between sepsis patients and controls. 30 Interestingly, the positive correlation between the incidence of sepsis and the Cys(98)Gly lipopolysaccharide binding protein (LBP) polymorphism was only observed in the Patients with severe sepsis were included in the study with approval of the local ethics board and following informed consent of the participants or their first-degree relatives. The diagnosis of severe sepsis was based on the consensus criteria of the SCCM/ACCP committee. 1 The Acute Physiology and Chronic Health Evaluation II (APACHE II) score, 19 the multiple organ failure (MOF) score, 20 and the Septic Organ Failure Assessment (SOFA) score 21 were used to assess the severity of disease. DNA was extracted using the QIAamp blood kit (QIAGEN). The CD14 promoter was amplified using the primers:
5′-TTG.GTG.CCA.ACA.GAT.GAG.GTT.CAC-3′ and 5′-TTC.TTT.CCT.ACA.CAG.CGG.CAC.CC-3′
in a total volume of 50 l (1U Taq DNA polymerase, 50 pmol of each primer, 200 nmol of each dNTP, 1.5 mmol Mg 2+ ) in MicroAmp PCR tubes and the Perkin-Elmer 9600 thermocycler. The initial denaturation was at 95°C for 1.5 min followed by 35 cycles of a 20 sec at 93°C, 30 sec at 62.5°C and a 90 sec at 72°C. The final extension was set at 5 min. 15 l of the PCR products were digested with 10U of HaeIII in a total volume of 25 l overnight at 37°C. All reagents were manufactured by Roche.
a Frequencies of the alleles were compared between the groups using the chi-square test in 3 × 2 fields. No significant difference was observed between patients and controls or survivors and non-survivors, respectively. subgroup of males. The lack of a correlation of a functional CD14 polymorphism to sepsis, in contrast, in this study may be explained by the potential relevance of other receptors interacting with LPS. Thus other molecules, for example CD55 31 are important in LPS signalling and also in part LBP dependent. The relevance of CD14 recently also has been questioned based on detection of the Toll-like receptor 4 (TLR4) 32 which is coupled to LPS responsiveness in mice. An increased LPS-dependent production of matrix metalloproteinase-9, however, was detected in TLR4 knock out mice 33 suggesting that this receptor taken alone is not essential for LPS signalling.
In an animal model it was proven that males are more susceptible to septic insults than females. 34 Similar results have been obtained in humans. 2, 35 Also, in this study, a trend towards a lower frequency of genotypes associated with higher expression of CD14 was detected in female sepsis patients only. However, no significance was reached for this observation despite analysis of 84 female patients and 119 female controls.
A few genetic markers have been studied in connection to the likelihood of sepsis development or sepsis mortality without the involving gender as a risk factor. The NcoI polymorphism in the tumour necrosis factor locus was significantly associated with mortality 36 and the polymorphism in the interleukin-1 receptor antagonist was associated with the incidence of severe sepsis. 37 The further identification of such risk alleles associated with increased probability of sepsis development is especially of interest for the clarification of pathomechanisms of sepsis including important pathways of receptor acti-vation and could be important for stratification of therapy.
